Analgesia et al. Dr Will Dooley
|
|
- Aldous Simon
- 5 years ago
- Views:
Transcription
1 Analgesia et al. Dr Will Dooley
2 Plan Pain assessment Acute vs. Chronic pain Overdose / Toxicity Some calculations Other common meds Anti-emetics Laxatives
3 Pain assessment The 5 th Vital Sign History, History, History S ite O nset C haracter R adiation A ssociated symptoms T ime E xcaerbating/reliveing factors S everity
4 Pain assessment
5
6 Common Analgesia Paracetamol NSAIDs Weak opioids Strong opioids
7 Paracetamol (Acetominophen) 500mg-1g QDS (Max. 4g/24hrs) PO/PR/IV Analgesia / Anti-pyrexial Onset of action mins Half life 1-4 hours Metabolised by the liver and is hepatotoxic Metabolites are then excreted by the kidney MOA poorly understood? COX inhibition
8 Ferner R E et al. BMJ 2011;342:bmj.d by British Medical Journal Publishing Group
9 Factors that increase the risk of liver injury High chance of glutathione depletion: - Malnourished - Eating disorders (anorexia or bulimia) - Failure to thrive or cystic fibrosis in children - AIDS - Cachexia - Chronic Alcoholism
10 Case of Overdose 44yo male Found unconscious with multiple packets of empty medications. Lives alone, was found by visitor. PMH- depression (previous suicide attempts), chronic ETOH abuse, malnourished. SH- Unemployed What are his risk factors for suicide? What more would you ask in the history??
11 Paracetamol Overdose History / History / History HPC Dose-?reliable historian / mixed Time once or staggered overdose Symptoms nausea and vomiting RUQ pain Psych- intentional / support / planned / alone / cry for help / warning / letter PMH ETOH Abuse Previous DSH / Suicide attempts Chronic Liver Disease DH Enzyme inducing drugs (e.g. Carbamazepine, phenobarbital, phenytoin, rifampicin, St John s wort etc.)
12 Treatment of Paracetamol OD Activated charcoal Decreases absorption of Paracetamol Needs to be given quickly (within 1hr) N-acetylcysteine (NAC) Antedote Acts as precursor to glutathione to increase levels and reduce liver damage Adverse effects Nausea and vomiting Anaphylactoid reaction which is histamine mediated
13 NAC use 1. Do they need treatment 2. Dose of treatment
14 Case 44yo male, PMH- depression (previous suicide attempts), chronic ETOH abuse, malnourished. Found unconscious with multiple packets of meds. 1. Do they need treatment 2. Dose of treatment
15 Would you treat these? 1.Overdose of 15x500mg tablets at 12:00. Blood at 18:00. PPC= 100mg/litre 2.Overdose of 24x500mg tablets at 09:00. Blood at 17:00 PPC= 30mg/litre 3.Overdose at 20:00?amount. Blood at 07:00. PPC= 30mg/litre What would you do? 4.Staggered OD between 09:00 and 16:00. Admits taking 50 Paracetamol tablets. Presents at Overdose at 08:00. Admits taking 5 tablets with ETOH XS. Presents at 11:00.
16 Would you treat these? 1.Overdose of 15x500mg tablets at 12:00. Blood at 18:00. PPC= 100mg/litre 2.Overdose of 24x500mg tablets at 09:00. Blood at 17:00 PPC= 30mg/litre 3.Overdose at 20:00?amount. Blood at 07:00. PPC= 30mg/litre What would you do? 4.Staggered OD between 09:00 and 16:00. Admits taking 50 Paracetamol tablets. Presents at Overdose at 08:00. Admits taking 5 tablets with ETOH XS. Presents at 11:00.
17 Case 54yo female, PMH- depression (previous suicide attempts), chronic ETOH abuse, malnourished. Found unconscious with multiple packets of meds. 1. Do they need treatment 2. Dose of treatment
18 2. Dose of treatment Total dose (300 mg/kg in 20 hours) 150 mg/kg in 200 ml (glucose 5%) over first 0.25 hours 50 mg/kg over next 4 hours in 500 ml 100 mg/kg over next 16 hours in 1000 Ml What dose regime would you prescribe for a 50kg patient? What rate (mls/hr) are required? 1. 50x150 = 7.5g NAC in 200ml glucose 5% over 15 minutes 200mls in 15 mins = 800mls / hr 2. 50x50 = 2.5g NAC in 500ml glucose 5% over 240 minutes 500mls in 240 mins = 125mls / hr x50 = 5g NAC in 1000ml glucose 5% over 960 minutes 1000mls in 960 mins = 62mls / hr
19 Liver Transplant Criteria for possible transplant: - Metabolic Acidosis - Arterial ph less than Hepatic encephalopathy grade III/IV and serum creatinine concentration >300 µmol/l and prothrombin time >100 seconds - Arterial lactate concentration >3.5mmol/L on admission or >3.0mmol/L 24 hours after paracetamol ingestion or after fluid resuscitation Discuss with liver transplant unit as soon as the possible need is identified
20 Non-Steroidal Anti-Inflammatory Drugs Drug name Dose Anti-inflammatory Side effect risk Ibuprofen mg TDS + + Naproxen 500mg BD Diclofenac mg total/day Indometacin mg total/day MOA: COX 1 and COX 2 inhibitors so inhibit prostaglandin production Indications: inflammatory conditions e.g. inflammatory arthritidies, rheumatoid arthritis, osteoarthritis, back pain, soft tissue injury Side Effects: COMMON especially in elderly Gastric- indigestion/nausea and gastric erosions (+/- UGI Bleed). Co-prescribe proton pump inhibitor if patient also on anti-coagulant Or consider COX-2 inhibitor e.g. Celecoxib (note CV risks) Respiratory: Bronchospasm- type 1 hypersensitivity reaction. C/I asthmatic Renal: Acute kidney injury, acute worsening of chronic renal failure
21 Opioids Mode of action - Presynaptic inhibition of production of neurotransmitters - Postsynaptic suppression activity in nociceptive pathway - Increased transmission of the descending inhibition
22 Opioids Morphine SC/IM/PO Titrate to symptoms/response Side effects Nausea and vomiting usually co-prescribe antiemetic (e.g. Metoclopramide) Constipation usually co-prescribe laxative (e.g. lactulose) Drowsiness Respiratory depression Overdose Accidental / Iatrogenic / Intentional Reversal with NALOXONE 400mcg-0.2mg IV (increased by 100mcg/ 2 mins PRN) Naloxone half life < Morphine half life (so may need multiple doses)
23 Opioids Codeine 30-60mg 4 hourly (max 240mg/24hrs) Orally Analgesia (normally used in combination with above e.g. co-codamol/co-dydramol) Side effects Constipation Tramadol mg 4 hourly Orally (rarely IV) Opioid action + enhancement of the serotonergic and adrenergic pathways Fewer typical opioid side effects Fentanyl Patches 25 / 100 ug/hr Change every 72 hours
24 Patient Controlled Analgesia Allows self administration of pre-determined dose of medication e.g. morphine Can determine: - Dose (usually start with 1mg morphine) - Maximum dose (over 24hours) - Lock-out period (usually 5 minutes)
25 Palliative Symptom Control Palliative Care; Active & total care of incurable disease aim to improve quality of life within wide MDT Symptoms can be caused by disease or treatment Detailed history and examination required to determine cause/best treatment options Main symptom groups: - GI Symptoms e.g. nausea/vomiting, anorexia, constipation, bowel obstruction - Respiratory Symptoms e.g. secretions Secretion can be treated with Glycopyrrolate - Other symptoms e.g. Anxiety/agitation Treated with benzodiazpeine e.g. midazolam - Pain Symptoms
26 Pain Control in Palliative Care 70% cancer patients experience moderate to severe pain Prescribe regular analgesia with PRN/Breakthrough back-up WHO Analgesia ladder exists for analgesia management decisions
27 Case Mrs CA is a 80yo has known inoperable metastatic breast cancer. She is complaining of significant pain which has previously been managed with non-opioid analgesia. What dose of morphine would you prescribe? Morphine Sulphate 5-10mg every 4 hours with Morphine Sulphate 5-20mg PRN 2-4hrly
28 Case Mrs CA s pain is relieved by Morphine Sulphate 10mg but the relief is not sustained until the next dose 4 hours later. How would you change the regular prescription? Increase dose by 50% So now; Morphine Sulphate 15mg every 4 hours with Morphine Sulphate 5-20mg PRN 2-4hrly
29 Case Mrs CA is eventually controlled over a 24 hour period using morphine sulphate as prescribed below: 0800 Morphine Sulphate 15mg 1200 Morphine Sulphate 15mg 1400 Morphine Sulphate 5mg 1600 Morphine Sulphate 15mg 2000 Morphine Sulphate 15mg 2100 Morphine Sulphate 5mg 2200 Morphine Sulphate 10mg 2400 Morphine Sulphate 15mg 0400 Morphine Sulphate 15mg 0600 Morphine Sulphate 10mg Would you change the prescription? If so, how?
30 Case To change regular immediate acting morphine prescription into regular prescription Work out total 24 hour analgesia requirement to control pain 0800 Morphine Sulphate 15mg 1200 Morphine Sulphate 15mg 1400 Morphine Sulphate 5mg 1600 Morphine Sulphate 15mg 2000 Morphine Sulphate 15mg Total = 120mg 1. Change to Controlled Release morphine preparation Either : Morphine Sulphate MR / MST 120mg OD or 60mg BD 2. Plus Breakthrough Pain prescription PRN One-sixth of total dose Morphine Sulphate 20mg PRN 2100Morphine Sulphate 5mg 2200Morphine Sulphate 10mg 2400 Morphine Sulphate 15mg 0400 Morphine Sulphate 15mg 0600 Morphine Sulphate 10mg REMEMBER SIDE EFFECTS
31 Spinal vs. Epidural
32 Anti-emetics Cyclizine 50mg TDS PO/IM/IV Anti-histamine Post op / GI obstruction / motion sickness / morning sickness s/e: sedation Ondansetron 4-8mg BD PO/IM/IV 5HT3 antagonist Chemo or radiotherapy nausea s/e: dry mouth Metoclopramide 10-20mg TDS PO/SC/IM/IV Dopamine antagonist GI causes, migraine, opioids s/e Domperidone 10-20mg TDS PO Dopamine antagonist Parkinson Disease, chemotherapy Haloperidol mg PO/SC Dopamine antagonist Opiate s/e, post op, chemo/radiotherapy
33 Laxatives Bulk-forming Increase faecal mass which stimulates perstalisis. For those with small hard stools. e.g. Dietary fibre, wheat bran, Ispaghula Husk Osmotic Non-absorbable salts which increase water retained in large bowel e.g. Lactulose, magnesium sulphate, macrogols Stimulant Increase intestinal motility. s/e abdo cramping e.g. Senna, docusate sodium Suppositories e.g. glycerol Enemas e.g. docusate sodium, arachis oil
34 Summary Discussed common analgesia Acute analgesia Chronic/Palliative prescribing Paracetamol Overdose Laxatives/Anti-emetics
35 Calculations
36 Calculations % Adrenaline. How much adrenaline (in grams) in 1 litre of saline? Same as 1:10,000 adrenaline So 1 unit adrenaline in 10,000 units saline Or 1g Adrenaline in 10,000ml saline So 0.1g in 1 litre (one decimal place to the right) 2. What is the minimum urine output (mls) for a 80kg patient over 4 hrs? UO > 0.5 ml / kg / hr So at least 0.5 x 80 x 4 = 160ml A. 80ml B. 100mls C. 40mls D. 160mls E. 240mls A. 1g B. 0.1g C. 0.01g D. 10g E. 100g
37 Calculations 3. Patient presents with burns from fire. Effecting both his arms, his face and head. What percentage body area has been effected? A. 8% B. 12% C. 27% D. 42% E. 50%
38 Herndon Rule of 9s Arm 9% Head 9% Neck 1% Leg 18% Anterior trunk 18% Posterior trunk 18%
39 GOOD LUCK!!! Take your time Read and think about the question (any clues?) Is your answer sensible? SMILE +/- Enjoy
Analgesia. Dr William Dooley. et al.
Analgesia Dr William Dooley et al. Plan Pain assessment Acute vs. Chronic pain Overdose / Toxicity Some calculations Other common meds Anti-emetics Laxatives Pain assessment The 5 th Vital Sign History,
More informationAnalgesia. Dr William Dooley. et al.
Analgesia Dr William Dooley et al. Plan Pain assessment Acute vs. Chronic pain Overdose / Toxicity Other common meds Anti-emetics Laxatives Some calculations Pain assessment The 5 th Vital Sign History,
More informationAnalgesia. Dr William Dooley. et al.
Analgesia Dr William Dooley et al. Plan Pain assessment Discuss common analgesia Modes of action and common S/E Acute and Chronic pain management Overdose / Toxicity Some calculations Other common meds
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More information21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content
Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for
More informationADULT (>16) ACUTE SICKLE PAIN GUIDELINE
ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ID 2013 065 Author s Name Dr Anna Wood Author s Job Title Consultant Haematologist Division Consultant Haematologist Department Haematology Version number 3 Ratifying
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationBACKGROUND Measuring renal function :
A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationIbuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN
Ibuprofen Ibuprofen and Paracetamol: prescribing overview Sarah Holloway Macmillan CNS in palliative care NSAID Non-selective COX inhibitor Oral bioavailability: 90% Onset of action: 20-30 mins (can take
More informationdisease or in clients who consume alcohol on a regular basis. bilirubin
NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A
More informationPAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationPain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017
Pain management in Paediatric Palliative Care Dr Jane Nakawesi 14 th August 2017 Content Management of pain in children Non pharmacological Pharmacological Exit level outcomes The participants will: Know
More informationEnhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice
Enhanced Community Palliative Support Services Lynne Ghasemi St Luke s Hospice Learning Outcomes Define the different types of pain Describe the process of pain assessment Discuss pharmacological management
More informationDR J HARTY / DR CM RITCHIE / DR M GIBBONS
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Paracetamol Poisoning DR J HARTY / DR CM RITCHIE / DR M GIBBONS Medicine Acute Date Uploaded: 16 th September 2014 Review Date
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationConstipation. Myeloma Infosheet Series. Symptoms and complications. Infoline:
Constipation This Infosheet explains what constipation is, what causes it in myeloma patients, what the symptoms of it are, how it is treated and some tips for self-management. What is constipation? Constipation
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More informationPrescribing and Administration of Analgesia within Maternity
Prescribing and Administration of Analgesia within Maternity CONTENTS Introduction and Who The Guideline Applies To... 2 UHL Paracetamol Prescribing Guideline... 2 Oral dosing... 2 Intravenous dosing...
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each capsule contains PARACETAMOL 500mg For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PARACETAMOL 500mg CAPSULES Boots Paracetamol 500mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains PARACETAMOL
More informationPAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain
Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name
More information5 MUSCULOSKELETAL SYSTEM
5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every
More informationBerkshire West Area Prescribing Committee Guidance
Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 80mg Suppositories 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 80mg Paracetamol For a full list of
More informationAcute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)
Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Introduction The majority of acute painful crises in patients with sickle cell disease will be managed independently
More informationDoncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary
Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Tipol 75mg Suppositories Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 75mg of paracetamol For a full list of excipients,
More informationPalliative care for patients with brain cancer
Palliative care for patients with brain cancer Lyn Cave Clinical Nurse Specialist Palliative Care Hospital2Home (H2H) Dr Jayne Wood Clinical Lead Palliative Care The Royal Marsden and Royal Brompton Palliative
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More informationNausea and Vomiting in Palliative Care
Nausea and Vomiting in Palliative Care Definitions Nausea - an unpleasant feeling of the need to vomit Vomiting - the expulsion of gastric contents through the mouth, caused by forceful and sustained contraction
More informationConstipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment
CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning
More informationPrimary Care Constipation Guidelines. Version 1 November 2016
Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationPAIN PODCAST SHOW NOTES:
PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of
More informationPARACOD Tablets (Paracetamol + Codeine phosphate)
Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s
More informationSymptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationConservative Management of Uraemia
Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist
More informationManaging Care at End of Life:
Managing Care at End of Life: Physical Suffering Pain & Dyspnea Verna Sellers, MD, MPH, AGSF Medical Director Centra PACE Lynchburg, Virginia 1 Speaker Disclosures: Dr. Sellers has disclosed that she has
More informationAssociate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008
Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes
More informationGuidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).
Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the
More informationPractical Management Of Osteoporosis
Practical Management Of Osteoporosis CONFERENCE 2012 Education Centre, Bournemouth.19 November The following companies have given funding towards the cost of this meeting but have no input into the agenda
More informationSymptom Control in the Community Setting. Dr Andrew Tysoe-Calnon
Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT PARACETAMOL 500mg CAPSULES 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol 500mg For the full list of excipients see section6.1.
More informationUsing Evidence Based Medicine to Ethically Provide End of Life Symptom Control
Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial
More informationSalicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre.
Aspirin poisoning CLINICAL FEATURES Salicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre. Severe poisoning causes
More informationManagement of Acute Pain
Management of Acute Pain SLCOA National Guidelines Contents List of Contributors 68 Introduction 69 Acute pain service 69 Methods available (post-op analgesia) 74 Selecting the correct method /s 82 Monitoring
More informationPalliative Care. Pocketbook 4
Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11
More informationMetabolism Paracetamol is metabolised in the liver and excreted in the urine mainly as glucuronide and sulphate conjugates.
FEBRAMOL Composition Febramol 150 Suppositories Each suppository contains Paracetamol 150 mg. Suppositories, Tablets & Syrup Febramol 300 Suppositories Each suppository contains Paracetamol 300 mg. Each
More informationPain relief after major surgery
Page 1 of 6 Pain relief after major surgery Introduction The aim of this leaflet is to tell you about the main pain relief options available after major surgery. You will probably only need this for the
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationPain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan
Pain management in palliative care Dr. Stepanie Lippett and Sister Karen Davies-Linihan contents Concept of total pain Steps in pain management Recognising neuropathic pain WHO analgesic ladder Common
More informationPain CONCERN. Medicines for long-term pain. Opioids
Pain CONCERN Medicines for long-term pain Opioids Opioids are a group of medicines that come from the extract of poppy seeds or other medicines that work in the same way. Types of opioid The first opioids
More informationSecond term/
Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic
More informationSIMPLY. Fluids. Dr William Dooley
SIMPLY. Fluids Dr William Dooley Plan Fluid management Resuscitation Routine Maintenance Replacement Redistribution Reassessment Common Errors Calculations Assessment?ORAL vs. IVF History Limited intake
More informationMedicines to treat pain in adults. Information for patients and carers
Medicines to treat pain in adults Information for patients and carers It is common to feel some pain after having an operation (surgery), trauma or an infection. Controlling pain is an important part of
More informationRenal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life
Guidance for Anticipatory prescribing for patients in renal failure (egfr
More informationEnd of life prescribing guidance
End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly
More informationNarcotic Analgesics. Jacqueline Morgan March 22, 2017
Narcotic Analgesics Jacqueline Morgan March 22, 2017 Pain Unpleasant sensory and emotional experience with actual or potential tissue damage Universal, complex, subjective experience Number one reason
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationAlgorithms for Symptom Management. In End of Life Care
Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the
More informationMigraleve, Migraleve Pink and Migraleve Yellow Product Information
Migraleve, Migraleve Pink and Migraleve Yellow Product Information Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard Adverse events should also
More informationCare in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More informationPalliative Care Impact Survey
September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the
More informationClinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults
Clinical Guideline Guidelines for the use of opioid analgesics in the management of acute pain in adults Document detail Document location West Kent and MTW Formulary Version 1.0 Effective from July 2017
More informationPAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A
More informationSIMPLY. Fluids. Dr Will Dooley
SIMPLY. Fluids Dr Will Dooley Plan Maintenance vs Resuscitation Prescribing Common Errors Calculations Drip rates Case 54 yo presents with severe diarrhoea and vomiting. How would you proceed? Assessment
More informationUnderstanding your take home medications from the surgical ward. Information for Patients
Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for
More informationProtocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians.
NY&AWC Medicines Management Team Protocol to support reducing the use of and the effective use of laxatives Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols
More informationAnalgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
More informationAnticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO
Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationComplex Symptom Management at the End of Life of Pediatric Patients
Complex Symptom Management at the End of Life of Pediatric Patients Justin N Baker, MD, FAAP, FAAHPM Chief, Division of Quality of Life and Palliative Care Director, Hematology/Oncology Fellowship Program
More informationScott Akin MD FAAFP
Scott Akin MD FAAFP sakin@emory.edu I have no financial disclosures Outline Review key palliative care articles of 2016 related to pain and symptom management AAHPM PC-FACS (monthly review of literature)
More informationPRODUCT INFORMATION CODAPANE XTRA Paracetamol 500 mg and Codeine Phosphate 15 mg Tablets
PRODUCT INFORMATION CODAPANE XTRA Paracetamol 500 mg and Codeine Phosphate 15 mg Tablets NAME OF THE MEDICINE Active Ingredients: Paracetamol and Codeine Phosphate Paracetamol: Molecular Formula: C 8 H
More informationAgonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone
Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold
More informationPalliative Care Formulary
Palliative Care Formulary 2016-2019 This formulary for pain and symptom management in adults is intended as a guide for prescribers in hospital and community. Special care should be taken when prescribing
More informationAttach patient label here. Physician Orders ADULT: Palliative Care Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Palliative Care Phase, When to Initiate: Palliative Care Phase Admission/Transfer/Discharge Patient Status Initial
More informationRenal Palliative Care Last Days of Life
Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr
More informationDATA SHEET. PANADOL Mini Caps Capsule shaped tablet with a gelatin coating which is one half green and the other half white.
PANADOL TABLETS PANADOL MINI CAPS DATA SHEET Proprietary (Trade) Name: PANADOL Active ingredient: Paracetamol (BP) 500 mg/tablet PRESENTATIONS White, film-coated tablet with bevelled edge, shallow convex,
More informationFDA hormone replacement therapy Web site 6
TABLE OF CONTENTS Caring for pain at UIMCC 1-5 FDA hormone replacement therapy Web site 6 P&T Committee Formulary Action - September 2003 6 Caring for pain at UIMCC The International Association for the
More informationGUIDELINES AND AUDIT IMPLEMENTATION NETWORK
GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management
More informationPAIN. Physiology of pain relating to pain management
PAIN Physiology of pain relating to pain management What is pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. (Melzac and Wall) The generation of pain
More informationPRODUCT INFORMATION Panadeine EXTRA
PRODUCT INFORMATION Panadeine EXTRA COMPOSITION Each caplet brand of capsule-shaped tablet contains: Paracetamol 500 mg Codeine phosphate 15 mg and Maize Starch Purified Talc Pregelatinised Maize Starch
More informationThis survey aims to look at individual practice and can be completed by any healthcare professional.
This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)
More informationPANADOL COLD & FLU MAX HOT LEMON Powder for Oral Solution DATA SHEET
PANADOL COLD & FLU MAX HOT LEMON Powder for Oral Solution Paracetamol (BP) 1000mg/sachet DATA SHEET Presentation Pale yellow, free flowing heterogeneous powder with and odour of lemon Indications Fast,
More informationPrimary care review of Tramadol Prescribing
Primary care review of Tramadol Prescribing Aim of the Audit To ensure the prescribing of tramadol is safe, appropriate and regularly reviewed, in line with local chronic pain guidelines 1 Background Tramadol
More informationConstipation. AL amyloidosis Infosheet Series. Symptoms and complications. Infoline:
Constipation This Infosheet explains what constipation is, what causes it in AL amyloidosis patients, the signs and symptoms, how it is treated and tips for self-management/prevention. What is constipation?
More informationAdult Opioid Prescribing Guidelines for Acute or Persistent Pain
Adult Opioid Prescribing Guidelines for Acute or Persistent Pain Author: Sponsor/Executive: Responsible committee: Consultation & Approval: (Committee/Groups which signed off the policy, including date)
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationSCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets
SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less S1 For pack sizes of more than 24 tablets PROPRIETARY NAME: AND DOSAGE FORM PANADO MELTABS (Tablets) COMPOSITION: Each tablet contains 500 mg
More informationNOTOPAIN CAPLETS. Diclofenac Sodium + Paracetamol. Composition. Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg.
NOTOPAIN CAPLETS Diclofenac Sodium + Paracetamol Composition Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg Pharmacology Phamacodynamics Diclofenac relieves pain and inflammation
More information